Anika Therapeutics Inc (ANIK)
24.57
-0.12
(-0.49%)
USD |
NASDAQ |
May 24, 16:00
24.48
-0.10
(-0.39%)
After-Hours: 20:00
Anika Therapeutics Free Cash Flow: -4.142M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -4.142M |
December 31, 2023 | -7.215M |
September 30, 2023 | -11.06M |
June 30, 2023 | -15.79M |
March 31, 2023 | -4.889M |
December 31, 2022 | -3.077M |
September 30, 2022 | 2.316M |
June 30, 2022 | 2.076M |
March 31, 2022 | 2.907M |
December 31, 2021 | 3.254M |
September 30, 2021 | 2.047M |
June 30, 2021 | 6.863M |
March 31, 2021 | 8.267M |
December 31, 2020 | 11.44M |
September 30, 2020 | 22.05M |
June 30, 2020 | 26.08M |
March 31, 2020 | 27.07M |
December 31, 2019 | 34.18M |
September 30, 2019 | 31.27M |
June 30, 2019 | 31.28M |
March 31, 2019 | 30.64M |
December 31, 2018 | 30.26M |
September 30, 2018 | 24.92M |
June 30, 2018 | 24.80M |
March 31, 2018 | 25.10M |
Date | Value |
---|---|
December 31, 2017 | 31.83M |
September 30, 2017 | 31.99M |
June 30, 2017 | 31.06M |
March 31, 2017 | 22.59M |
December 31, 2016 | 10.43M |
September 30, 2016 | 14.69M |
June 30, 2016 | 14.13M |
March 31, 2016 | 28.58M |
December 31, 2015 | 30.69M |
September 30, 2015 | 35.88M |
June 30, 2015 | 35.02M |
March 31, 2015 | 28.83M |
December 31, 2014 | 38.42M |
September 30, 2014 | 32.10M |
June 30, 2014 | 32.36M |
March 31, 2014 | 32.01M |
December 31, 2013 | 24.72M |
September 30, 2013 | 21.52M |
June 30, 2013 | 16.18M |
March 31, 2013 | 16.99M |
December 31, 2012 | 9.044M |
September 30, 2012 | 11.30M |
June 30, 2012 | 11.93M |
March 31, 2012 | 5.650M |
December 31, 2011 | 8.773M |
Free Cash Flow Range, Past 5 Years
-15.79M
Minimum
Jun 2023
34.18M
Maximum
Dec 2019
8.247M
Average
3.080M
Median
Free Cash Flow Benchmarks
The Cooper Companies Inc | 136.00M |
Staar Surgical Co | 20.88M |
OrthoPediatrics Corp | -47.78M |
NexGel Inc | -4.379M |
Innovative Eyewear Inc | -6.070M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -0.126M |
Cash from Investing (Quarterly) | -1.808M |
Cash from Financing (Quarterly) | -2.273M |
Free Cash Flow Per Share (Quarterly) | -0.1316 |
Free Cash Flow to Equity (Quarterly) | -1.934M |
Free Cash Flow to Firm (Quarterly) | -1.934M |
Free Cash Flow Yield | -1.15% |